ASPEN AEROGELS INC
ASPNdata completeness 100%14 fiscal years on fileASPEN AEROGELS INC earns about -55% on invested capital, but has diluted owners by 171% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $121.6M1 | $180.4M2 | $238.7M3 | $452.7M3 | $271.1M3 |
| Net income | −$37.1M4 | −$82.7M5 | −$45.8M6 | $13.4M6 | −$389.6M6 |
| Operating cash flow | −$18.6M7 | −$94.4M8 | −$42.6M9 | $45.5M9 | $32.9M9 |
| Capital expenditure | $13.8M10 | $178M11 | $175.5M12 | $86.3M12 | $37.4M12 |
| Free cash flow (derived) | −$32.4M7 | −$272.4M8 | −$218.1M9 | −$40.7M9 | −$4.58M9 |
| Total debt | — | — | — | $134.5M13 | $90.6M13 |
| Cash & equivalents | $76.6M14 | $281.3M15 | $139.7M16 | $220.9M17 | $156.9M17 |
| Diluted shares | 30.4M | 39.4M | 69.4M | 80.3M | 82.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $28.61 of net worth that earned you −$47.32 and generated −$0.56 of cash last year, against $11 of debt.
It earned an average -55% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 171% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 33% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0000950170-24-028127 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-029252 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K/A · period ending 2023-12-31 · accession 0001193125-26-119892 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0000950170-24-028127 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-029252 (NetIncomeLoss)
- 10-K/A · period ending 2023-12-31 · accession 0001193125-26-119892 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0000950170-24-028127 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-029252 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2023-12-31 · accession 0001193125-26-119892 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0000950170-24-028127 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0000950170-25-029252 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K/A · period ending 2023-12-31 · accession 0001193125-26-119892 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K/A · period ending 2024-12-31 · accession 0001193125-26-119892 (LongTermDebtCurrent)
- 10-K · period ending 2021-12-31 · accession 0000950170-23-008476 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-028127 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0000950170-25-029252 (CashAndCashEquivalentsAtCarryingValue)
- 10-K/A · period ending 2024-12-31 · accession 0001193125-26-119892 (CashAndCashEquivalentsAtCarryingValue)